Browse by all authors Browse By Author Name - Nieda,+M.

Browse Results (27 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Nieda, M., Nicol, A. J., Koezuka, Y., Kikuchi, A., Takahashi, T., Nakamura, H., Furukawa, H., Yabe, T., Ishikawa, Y., Tadokoro, K. and Juji, T. (1999) Activation of human Valpha24NKT cells by alpha-glycoslceramide in a CD1d-restricted and Valpha24TCR-mediated manner. Human Immunology, 60 1: 10-19. doi:10.1016/S0198-8859(98)00100-1 45   84 Cited 88 times in Scopus88 0
Nieda, M, Nicol, A, Koezuka, Y, Kikuchi, A, Takahashi, T, Nakamura, H, Furukawa, H, Yabe, T, Ishikawa, Y, Tadokoro, K and Juji, T (1999) Activation of human V alpha 24NKT cells by alpha-glycosylceramide in a CD1d-restricted and V alpha 24TCR-mediated manner. HUMAN IMMUNOLOGY, 60 1: 10-19. doi:10.1016/S0198-8859(98)00100-1 33   84 Cited 88 times in Scopus88 0
Nicol, A., Nieda, M., Donaldson, C., DenningKendall, P., Bradley, B. and Hows, J. (1995) Analysis of cord blood CD34+ cells purified after cryopreservation. Experimental Hematology, 23 14: 1589-1594. 38   32 Cited 35 times in Scopus35
Takahashi, T., Nieda, M., Koezuka, Y., Nicol, A., Porcelli, S.A., Ishikawa, Y., Tadokoro, K., Hirai, H. and Juji, T. (2000) Analysis of human V alpha 24(+) CD4(+) NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. Journal of Immunology, 164 9: 4458-4464. 37   120 Cited 120 times in Scopus120
Lin, H, Nieda, M, Rozenkov, V and Nicol, AJ (2006) Analysis of the effect of different NKT cell subpopulations on the activation of CD4 and CD8 T cells, NK cells, and B cells. Experimental Hematology, 34 3: 289-295. doi:10.1016/j.exphem.2005.12.008 80   15 Cited 17 times in Scopus17 0
Denning-Kendall, P. A., Horsley, H., Nicol, A., Nieda, M., Bradley, B. and Hows, J. M. (1998) Clinical application of in vitro expansion of cord blood. Bone Marrow Transplantation, 22 Suppl 1: S63-S65. 30   4 Cited 4 times in Scopus4
Nicol, A. J., Tokuyama, H., Mattarollo, S. R., Hagi, T., Suzuki, K., Yokokawa, K. and Nieda, M. (2011) Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours. British Journal of Cancer, 105 6: 778-786. doi:10.1038/bjc.2011.293 55   26 Cited 30 times in Scopus30 0
Lin, H., Nieda, M., Hutton, J. F., Rozenkov, V. and Nicol, A. J. (2006) Comparative gene expression analysis of NKT cell subpopulations. Journal of Leukocyte Biology, 80 1: 164-173. doi:10.1189/jlb.0705421 48   14 Cited 15 times in Scopus15 0
Takahara, M., Miyai, M., Tomiyama, M., Mutou, M., Nicol, A.J. and Nieda, M. (2008) Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vy9y T cell activation. Journal of Leukocyte Biology, 83 3: 742-754. doi:10.1189/jlb.0307185 329   16 Cited 18 times in Scopus18 0
Hows, J., Nicol, A., DenningKendall, P., Donaldson, C., Nieda, M. and Bradley, B. (1996) Cord blood as an alternative source of haemopoietic stem cells. Annals of Oncology, 7 Suppl 2: 47-51. doi:10.1093/annonc/7.suppl_2.47 22   5 Cited 7 times in Scopus7 0
Nicol, A. J., Kikuchi, A., Nieda, M., Hutchins, C., Horley, D., Henry, J. and Durrant, S. T. (1999). Cytotoxic T-Lymphocyte therapy for a patient with chronic myeloid leukaemia. In: Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (65). 21 - 29 Oct, 1999. 28  
Nicol, A. J., Nieda, M., Koezuka, Y., Porcelli, S., Suzuki, K., Tadokoro, K., Durrant, S. T. and Juji, T. (2000) Dendritic cells are targets for human invariant Valpha24+ natural killer T-cell cytotoxic: An important immune regulatory function. Experimental Hematology, 28 3: 276-282. doi:10.1016/S0301-472X(99)00149-6 42   26 Cited 28 times in Scopus28 0
Nieda, M, Kikuchi, A, Nicol, A, Koezuka, Y, Ando, Y, Ishihara, S, Lapteva, N, Yabe, T, Tokunaga, K, Tadokoro, K and Juji, T (2001) Dendritic cells rapidly undergo apoptosis in vitro following culture with activated CD4(+) V alpha 24 natural killer T cells expressing CD40L. Immunology, 102 2: 137-145. doi:10.1046/j.1365-2567.2001.01175.x 50   13 Cited 12 times in Scopus12 0
Lin, H, Nieda, M and Nicol, AJ (2004) Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines. European Journal of Immunology, 34 10: 2664-2671. doi:10.1002/eji.200324834 71   30 Cited 30 times in Scopus30 0
Crough, T, Nieda, M, Morton, J, Bashford, J, Durrant, S and Nicol, AJ (2002) Donor-derived b2a2-specific T cells for immunotherapy of patients with chronic myeloid leukemia. Journal of Immunotherapy, 25 6: 469-475. doi:10.1097/00002371-200211000-00003 77   4 Cited 6 times in Scopus6 0
Tazbirkova, A., Okai, M., Horley, D. C., Crough, T. M., Maksoud, A., Nieda, M. and Nicol, A. J. (2003) Effects of leukapheresis protocol, cell processing and cryopreservation on the generation of monocyte-derived DC for immune therapy. Cytotherapy, 5 1: 31-39. doi:10.1080/14653240310000056 190   3 Cited 3 times in Scopus3 0
Lapteva, N, Nieda, M, Ando, Y, Nicol, A, Ide, K, Yamaura, A, Hatta-Ohashi, Y, Egawa, K, Juji, T and Tokunaga, K (2001) Gene expression analysis in human monocytes, monocyte-derived dendritic cells, and alpha-galactosylceramide-pulsed monocyte-derived dendritic cells. Biochemical And Biophysical Research Communications, 289 2: 531-538. doi:10.1006/bbrc.2001.6003 55   8 Cited 8 times in Scopus8 1
Crough, T, Nieda, M and Nicol, AJ (2004) Granulocyte colony-stimulating factor modulates alpha-galactosylceramide-responsive human V alpha 24(+) V beta 11(+) NKT cells. Journal of Immunology, 173 8: 4960-4966. 79   14 Cited 15 times in Scopus15
Nicol, A. J., Nieda, M., Koezuka, Y., Porcelli, S., Tadokoro, K., Durrant, S. T. and Juji, T. (2000) Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic antitumour activity through mechanisms distinct from T cells and natural killer cells.. Immunology, 99 2: 229-234. doi:10.1046/j.1365-2567.2000.00952.x 32   83 Cited 87 times in Scopus87 0
Okai, M, Nieda, M, Tazbirkova, A, Horley, D, Kikuchi, A, Durrant, S, Takahashi, T, Boyd, A, Abraham, R, Yagita, H, Juji, T and Nicol, A (2002) Human peripheral blood V alpha 24(+) V beta 11(+) NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells. Vox Sanguinis, 83 3: 250-253. doi:10.1046/j.1423-0410.2002.00217.x 66   35 Cited 35 times in Scopus35 0
Nicol, A. J., Kikuchi, A., Nieda, M., Schmidt, C., Giles, N., Horley, D., Henry, J. and Durrant, S. T. (1999). Human Va24+ NKT cells have anti-tumour activity against human melanoma. In: Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (65). 21 - 27 Oct, 1999. 49  
Kikuchi, A., Nieda, M., Schmidt, C., Koezuka, Y., Ishihara, S., Ishikawa, Y., Tadokoro, K., Durrant, S., Boyd, A., Juji, T. and Nicol, A. (2001) In vitro anti-tumour activity of α-galactosylceramide-stimulated human invariant Vα24+NKT cells against melanoma. British Journal of Cancer, 85 5: 741-746. doi:10.1054/bjoc.2001.1973 94   35 Cited 38 times in Scopus38 0
Crough, T, Purdie, DM, Okai, M, Maksoud, A, Nieda, M and Nicol, AJ (2004) Modulation of human V alpha 24(+)V beta 11(+) NKT cells by age, malignancy and conventional anticancer therapies. British Journal of Cancer, 91 11: 1880-1886. doi:10.1038/sj.bjc.6602218 65   32 Cited 31 times in Scopus31 0
Lickliter, J. D., Cox, J., McCarron, J., Martinez, N. R., Schmidt, C. W., Lin, H., Nieda, M. and Nicol, A. J. (2007) Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction. British Journal of Cancer, 96 4: 600-608. doi:10.1038/sj.bjc.6603599 58   22 Cited 25 times in Scopus25 0
Kashiwase, K, Kikuchi, A, Ando, Y, Nicol, A, Porcelli, SA, Tokunaga, K, Omine, M, Satake, M, Juji, T, Nieda, M and Koezuka, Y (2003) The CD1d natural killer T-cell antigen presentation pathway is highly conserved between humans and rhesus macaques. Immunogenetics, 54 11: 776-781. doi:10.1007/s00251-002-0527-8 38   17 Cited 17 times in Scopus17 0
Nieda, M, Okai, M, Tazbirkova, A, Lin, H, Yamaura, A, Ide, K, Abraham, R, Juji, T, Macfarlane, DJ and Nicol, AJ (2004) Therapeutic activation of V alpha 24(+)V beta 11(+) NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood, 103 2: 383-389. doi:10.1182/blood-2003-04-1155 559   227 Cited 238 times in Scopus238 0
Nieda, M, Nicol, A, Koezuka, Y, Kikuchi, A, Lapteva, N, Tanaka, Y, Tokunaga, K, Suzuki, K, Kayagaki, N, Yagita, H, Hirai, H and Juji, T (2001) TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukema cells. Blood, 97 7: 2067-2074. doi:10.1182/blood.V97.7.2067 53   101 Cited 103 times in Scopus103 0